Suzuken Co., Ltd.
Stock Price Chart
2026/09/21 UpdatedPrice Trend
2026/09/21 UpdatedPrice & Trading Details
2026/09/21 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/09/01Earnings Calendar
Updated 2026/09/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2013/08/04 | ¥28.00 | ¥34.79 | +24.3% |
| 2011/05/08 | ¥70.64 | ¥5.38 | -92.4% |
| 2006/08/09 | ¥45.91 | ¥34.28 | -25.3% |
Shareholder Composition
Updated 2026/09/01Major Holders
Updated 2026/09/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Columbia Fd.s Varbl Series TRT II-Columbia Varbl PORT. - Overseas Core
|
1.1M | -10.20% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
839.8K | -1.50% | |
|
John Hancock Investment Trust-Disciplined Value International Fund
|
651.9K | 0.00% | |
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
642.1K | +12.87% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
543.2K | +0.52% | |
|
Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund
|
421.8K | +2.78% |
Dividend History
Updated 2026/09/20| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥50 | -50.0% |
| 2025 | ¥100 | +11.1% |
| 2024 | ¥90 | +18.4% |
| 2023 | ¥76 | +5.6% |
| 2022 | ¥72 | - |
Financial Performance
2026/09/20 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,239,112M | ¥2,314,828M | ¥2,386,493M | ¥2,399,952M |
| Gross Profit | ¥167,332M | ¥179,694M | ¥185,249M | ¥192,231M |
| Operating Income | ¥20,116M | ¥32,605M | ¥34,876M | ¥37,125M |
| Pretax Income | ¥22,535M | ¥30,636M | ¥42,836M | ¥50,328M |
| Net Income | ¥14,393M | ¥20,345M | ¥29,016M | ¥34,496M |
| EPS | ¥163.19 | ¥236.47 | ¥357.88 | ¥454.58 |
| Operating Margin | 0.90% | 1.41% | 1.46% | 1.55% |
| Balance Sheet | ||||
| Total Assets | ¥1,141,717M | ¥1,146,097M | ¥1,228,686M | ¥1,113,831M |
| Total Equity | ¥417,686M | ¥411,208M | ¥416,306M | ¥407,291M |
| Total Liabilities | ¥724,031M | ¥734,889M | ¥812,380M | ¥706,540M |
| Cash | ¥141,377M | ¥109,026M | ¥181,830M | ¥102,655M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 36.58% | 35.88% | 33.88% | 36.57% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥9,520M | ¥37,270M | ¥87,216M | -¥65,079M |
| Investing CF | ¥1,439M | -¥46,361M | ¥10,350M | ¥20,378M |
| Financing CF | -¥11,599M | -¥26,219M | -¥31,716M | -¥35,483M |
| Free CF | -¥4,772M | ¥19,528M | ¥71,576M | -¥83,726M |
| Efficiency | ||||
| ROE | 3.45% | 4.95% | 6.97% | 8.47% |
| ROA | 1.26% | 1.78% | 2.36% | 3.10% |
Latest IR Information
-
Notice of Changes in Major Shareholders and Primary Beneficial Owners
A change report for a large shareholding was submitted on 2026-09-09, with changes in major shareholders and the primary beneficial owner. The new principal shareholder is Silchester International Investors LLP. Post-change voting rights share is 10.03%; pre-change was 8.80%. No...
Read more -
Announcement on the results of treasury stock acquisition through off-market purchases (ToSTNeT-3)
Treasury stock acquired: 990,000 shares, total amount 5,131,170,000 yen, acquisition date: 2026-09-03. Purpose of acquisition: to execute a flexible capital policy. Upper limit: 4,000,000 shares (upper limit relative to issued shares), acquisition period: from 2026-09-01 to 2027-03-19. Planned post-split upper...
Read more -
Notice of Share Buyback via Off-More-than-Open Auction (ToSTNeT-3) for Treasury Stock Acquisition
On September 3, 2026, at 8:45 AM, using ToSTNeT-3, ordinary shares will be purchased with a maximum of 1,200,000 shares and a maximum total amount of 6,219,600,000 yen. Purchases will continue in the market to the extent that the upper...
Read more -
Notice on the Impact of the 2023 Kumamoto Earthquake (Recovery Outlook for Kumamoto Factory and Impact on Current Period Performance)
Publicize the recovery outlook for the subsidiary factory affected by the Kumamoto earthquake (Kumamoto Factory). Recovery is expected around late October 2026, inventories are securing supply to avoid supply concerns. It is explained that the impact on consolidated results is...
Read more -
Notice regarding the resolution on share buyback
Decision to acquire treasury stock. Upper limit of 4,000,000 shares (5.91% of outstanding shares) with a total amount cap of 18 billion yen, and a period from September 1, 2026 to March 19, 2027. Following a stock split, the upper...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥6,023
Rating Score: 2.33 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Silchester Becomes Largest Shareholder in Suzuken with 10.03% Stake - marketscreener.com ↗
Suzuken - Forbes ↗
Company Information
About
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies. The Healthcare Product Development segment offers ethical drugs, diagnostic reagents, and medical devices and materials. The Community Healthcare and Nursing Care Support segment provides a range of pharmacy and nursing care services. The Healthcare Related Services segment offers contract distribution for manufacturers and contract distribution of orphan drugs. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
